Plots were calculated according to the time-independent free energy estimator described by Tiwary and Parrinello. 1 The energy surface for NOE is for the neutral molecule. Table S1 . Data collection and refinement statistics for BxGH99 complexes
E333Q -GlcChex

BxGH99-ManddMan
BxGH99-
ManddMan-1,2-α-mannobiose
BxGH99-ManGlucal
BxGH99-ManGlucal-2α-mannobiose (pETYSBLic), BxGH99 wild-type, E333Q and E336Q (pET28a). Single clones were shaken at 180 rpm and 37 °C in 50 ml tubes (Falcon) containing 5 ml LB media with 50 µg ml -1 kanamycin. Large-scale selective LB cultures in 2 l conical flasks were inoculated 1:1000 with starter cultures and shaken at 180 rpm and 37 °C until the OD 600 was higher than 1, induced using then switched to 16 °C for 24 h. Cell pellets were separated from the media by centrifugation, resuspended in 25 mM HEPES pH 7.0, 300 mM NaCl, 20 mM imidazole and lysed by sonication. The lysate was centrifuged twice and the supernatant was applied to a pre-equilibrated 5 ml HisTrap FF or FF crude column (GE). Protein bound to the column was eluted using imidazole gradient (up to 500 mM). Fractions containing purest protein were combined and concentrated using Amicon Ultra 30 kDa concentrator (Millipore). Further purification was done using a Sepharose S75 16/60 or 16/600 column equilibrated in 25 mM HEPES pH 7.0, 100 mM NaCl, 1 mM DTT, which was also used as the buffer for storage. Fractions containing pure GH99 proteins were combined, concentrated as previously, aliquoted, flash frozen in liquid nitrogen and stored at -80 °C.
BxGH99-ManNOE
BxGH99-
Crystallization and Data Collection
BxGH99 wild-type and E333Q variant were crystallized in darkness at 19 °C using 24-well plates (Greiner Bio-One) using hanging drop vapour diffusion method. Each 0. 
(2,3,4,6-Tetra-O-acetyl-α-D-mannopyranosyl)-(1→3)-(2,4,6-tri-O-acetyl-α-D-mannopyranosyl) bromide (12)
The octaacetate 11 (96.9 mg, 0.142 mmol) was dissolved in 33% w/v HBr/AcOH (0.1 mL, 0.507 mmol) and stirred for 3 h. The mixture was diluted with EtOAc (20 mL), poured into ice water and quickly washed with NaHCO 3 (3 × 10 mL), and brine (2 × 10 mL), then dried (MgSO 4 ) and co-evaporated with toluene under reduced pressure to afford the crude glycosyl bromide 12 as a viscous brown oil, which was used directly in the next step 
2,3,4,6-Tetra-O-acetyl-α-D-mannopyranosyl-(1→3)-(4,6-di-O-acetyl-1,2-dideoxy-D-mannopyranose (14)
A mixture of the glucal 13 (5.60 mg, 9.99 µmol) and 5% Pd/C (8.5 mg) in methanol (1.5 mL) was stirred under a hydrogen atmosphere for 2 h. The mixture was filtered through Celite and concentrated, followed by acetylation with acetic anhydride (0.5 mL) in pyridine (0. 
Benzyl 2-O-(2-O-acetyl-2,4,5-tri-O-benzyl-α-mannopyranosyl)-(1→2)-(4-C-[(tertbutoxycarbonyl)amino]methyl-4-deoxy-β-D-arabinopyranoside) (19)
Borane dimethyl sulfide complex (35.7 µL, 0.379 mmol) was added dropwise to nitrile 18 (57.1 mg, 0.0838 mmol) in anhydrous THF (3 mL), and the mixture was stirred under reflux for 24 h. MeOH (3 mL) was added dropwise and reflux continued for an additional 18 h. The solvent was evaporated under reduced pressure and the residue was azeotroped with MeOH (3 × 20 mL) and evaporated to dryness under reduced pressure. The residue was dissolved in THF/MeOH (1:3, 12 mL) and treated with 10% aq. Na 2 CO 3 (2 mL) and (Boc) 2 O (36.6 mg, 0.168 mmol). After 2 h the mixture was filtered and the filtrate concentrated under
